Opiant Pharmaceuticals Announces Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Acquisition By Indivior Plc
Opiant Pharmaceuticals Announces Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Acquisition By Indivior Plc
02/06/23, 1:03 PM
Location
Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) announced today the expiration of the waiting period under the United States (U.S.) Hart-Scott-Rodino Act of 1976, as amended (HSR Act), with respect to the previously announced agreement for Opiant to be acquired by Indivior PLC (LSE: INDV).